Xiamen Changrong Investment Management logo

Xiamen Changrong Investment Management

Asia, Fujian, China, Xiamen

Description

Xiamen Changrong Investment Management is an investment firm.

Investor Profile

Xiamen Changrong Investment Management has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series D (50%)
  • Series A (50%)

Country Focus

  • China (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xiamen Changrong Investment Management frequently co-invest with?

Co-Investments: 1
FengHe Fund Management
Asia, Guangdong, China, Huangpu
Co-Investments: 1
Sinovation Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
LI
North America, Kentucky, United States, California
Co-Investments: 1
Cowin Venture
Asia, Beijing, China, Beijing
Co-Investments: 1
Cenova
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CC
North America, Washington, United States, Spokane
Co-Investments: 1
BB
Asia, Kagoshima, Japan, China
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
ShenZhen GTJA Investment Group
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Xiamen Changrong Investment Management?

Amberstone Biosciences

Laguna Hills, California, United States

Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.

BiotechnologyHealth CareMedical
Series AJan 3, 2022
Amount Raised: $12,000,000
VivaVision Biotech

Shanghai, Shanghai, China

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.

Biotechnology
Series DApr 21, 2021
Amount Raised: $46,217,840